Antisense Modulation of Apolipoprotein B Expression

Details for Australian Patent Application No. 2011254024 (hide)

Owner Genzyme Corporation

Inventors Crooke, Rosanne M.; Geary, Richard S.; Yu, Zhengrong

Agent Wrays

Pub. Number AU-A-2011254024

Parent 2005272912

Filing date 14 December 2011

Wipo publication date 19 January 2012

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

12 January 2012 Complete Application Filed

19 January 2012 Application Open to Public Inspection

  Published as AU-A-2011254024

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011254025-hK1-Binding Proteins

2011254023-System for providing bets regarding intermediate points in a race event